DK0941994T3 - Pyrazolopyrimidiner og pyrazolotriaziner med 5-HT6 receptoraffinitet - Google Patents

Pyrazolopyrimidiner og pyrazolotriaziner med 5-HT6 receptoraffinitet

Info

Publication number
DK0941994T3
DK0941994T3 DK99102872T DK99102872T DK0941994T3 DK 0941994 T3 DK0941994 T3 DK 0941994T3 DK 99102872 T DK99102872 T DK 99102872T DK 99102872 T DK99102872 T DK 99102872T DK 0941994 T3 DK0941994 T3 DK 0941994T3
Authority
DK
Denmark
Prior art keywords
pyrazolotriazines
pyrazolopyrimidines
receptor affinity
affinity
receptor
Prior art date
Application number
DK99102872T
Other languages
Danish (da)
English (en)
Inventor
Michael Boes
Claus Riemer
Heinz Stadler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0941994T3 publication Critical patent/DK0941994T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK99102872T 1998-03-11 1999-03-03 Pyrazolopyrimidiner og pyrazolotriaziner med 5-HT6 receptoraffinitet DK0941994T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98104346 1998-03-11

Publications (1)

Publication Number Publication Date
DK0941994T3 true DK0941994T3 (da) 2003-09-08

Family

ID=8231568

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99102872T DK0941994T3 (da) 1998-03-11 1999-03-03 Pyrazolopyrimidiner og pyrazolotriaziner med 5-HT6 receptoraffinitet

Country Status (33)

Country Link
US (1) US6194410B1 (fr)
EP (1) EP0941994B1 (fr)
JP (1) JP3231288B2 (fr)
KR (1) KR100313181B1 (fr)
CN (1) CN1118468C (fr)
AR (1) AR016453A1 (fr)
AT (1) ATE240332T1 (fr)
AU (1) AU752408B2 (fr)
BR (1) BR9901095A (fr)
CA (1) CA2265095C (fr)
CZ (1) CZ291514B6 (fr)
DE (1) DE69907784T2 (fr)
DK (1) DK0941994T3 (fr)
ES (1) ES2198095T3 (fr)
HR (1) HRP990077B1 (fr)
HU (1) HUP9900589A1 (fr)
ID (1) ID23575A (fr)
IL (1) IL128869A (fr)
MA (1) MA26612A1 (fr)
MY (1) MY119536A (fr)
NO (1) NO312297B1 (fr)
NZ (1) NZ334526A (fr)
PE (1) PE20000337A1 (fr)
PL (1) PL331875A1 (fr)
PT (1) PT941994E (fr)
RU (1) RU2218340C2 (fr)
SG (1) SG78336A1 (fr)
SI (1) SI0941994T1 (fr)
TR (1) TR199900531A3 (fr)
TW (1) TW585865B (fr)
UY (1) UY25419A1 (fr)
YU (1) YU12099A (fr)
ZA (1) ZA991946B (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000059907A2 (fr) * 1999-04-06 2000-10-12 Du Pont Pharmaceuticals Company Pyrazolotriazines antagonistes de corticoliberine (crf)
DE19956791A1 (de) 1999-11-25 2001-05-31 Merck Patent Gmbh Neue Sulfonyloxazolamine
PE20020394A1 (es) 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
DE60218434T2 (de) * 2001-03-13 2007-11-08 Bristol-Myers Squibb Pharma Co. 4-(2-BUTYLAMINO)-2,7-DIMETHYL-8-(2-METHYL-6-METHOXYPYRID-3-YL) PYRAZOLO- 1,5-Aö-1,3,5-TRIAZIN, SEINE ENANTIOMEREN UND PHARMAZEUTISCH ANNEHMBARE SALZE ALS CORTICOTROPIN-RELEASING-FACTOR-REZEPTOR-LIGANDEN
MXPA03011244A (es) 2001-06-07 2004-02-27 Hoffmann La Roche Nuevos derivados de indol con afinidad por el receptor 5-ht6.
KR20040010709A (ko) 2001-06-15 2004-01-31 에프. 호프만-라 로슈 아게 5-ht6 수용체 친화력을 갖는 4-피페라지닐인돌 유도체
WO2003013510A1 (fr) * 2001-08-07 2003-02-20 Smithkline Beecham P.L.C. 3-arylsulfonyl-7-piperazinyl- indols, -benzofurans et benzothiophenes a affinite avec les recepteurs 5-ht6 pour le traitement de troubles du snc
WO2003053433A1 (fr) * 2001-12-20 2003-07-03 Wyeth Derives d'indolylalkylamine en tant que ligands de 5-hydroxytryptamine-6
US6642381B2 (en) * 2001-12-27 2003-11-04 Hoffman-La Roche Inc. Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
GB0202679D0 (en) * 2002-02-05 2002-03-20 Glaxo Group Ltd Novel compounds
UA78999C2 (en) * 2002-06-04 2007-05-10 Wyeth Corp 1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
US6875771B2 (en) 2002-07-26 2005-04-05 Bristol-Myers Squibb Company Pyridopyrimidine derivatives as 5-HT6 antagonists
US7196078B2 (en) * 2002-09-04 2007-03-27 Schering Corpoartion Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
DE60332846D1 (de) * 2002-09-04 2010-07-15 Pharmacopeia Llc Zur behandlung von krebserkrankungen geeignete pyrazolopyrimidine
US7329658B2 (en) * 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
EP1592690A1 (fr) * 2003-02-14 2005-11-09 Wyeth Derives de heterocyclyl-3-sulfonylazaindole ou -azaindazole utilises comme ligands de la 5-hydroxytryptamine-6
WO2004076458A1 (fr) 2003-02-28 2004-09-10 Teijin Pharma Limited Derives de pyrazolo[1,5-a]pyrimidine
GB0305559D0 (en) * 2003-03-11 2003-04-16 Teijin Ltd Compounds
US7585881B2 (en) * 2004-02-18 2009-09-08 Astrazeneca Ab Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
WO2005112936A1 (fr) * 2004-05-14 2005-12-01 The Regents Of The University Of Michigan Compositions et methodes associees aux inhibiteurs de la proteine kinase
SI1812440T1 (sl) * 2004-11-04 2011-04-29 Vertex Pharma Pirazolo(1,5-a)pirimidini, uporabni kot inhibitorji protein kinaz
RU2390523C2 (ru) * 2005-10-21 2010-05-27 Мицубиси Танабе Фарма Корпорейшн ПРОИЗВОДНОЕ ПИРАЗОЛ[1,5-a]ПИРИМИДИНА
RU2330854C2 (ru) * 2006-03-15 2008-08-10 Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" (ГОУВПО "ПГФА Росздрава") Способ получения конденсированных гем-диметилзамещенных амино-1,3,5-триазинов
KR20100119777A (ko) * 2008-01-24 2010-11-10 알라 캠, 엘엘씨 치환된 사이클로알카노[e 및 d] 피라졸로 [1,5―A]피리미딘/세로토닌 5―HT6 수용체의 길항제 및 이의 제조방법 및 이의 용도
RU2369600C1 (ru) * 2008-01-24 2009-10-10 Андрей Александрович Иващенко ЗАМЕЩЕННЫЕ 4-СУЛЬФОНИЛ-ПИРАЗОЛЫ И 3-СУЛЬФОНИЛ-ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ5-HT6 РЕЦЕПТОРОВ, АКТИВНЫЙ КОМПОНЕНТ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ЛЕКАРСТВЕННОЕ СРЕДСТВО И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
EP2248817B1 (fr) * 2008-01-24 2015-01-07 Alla Chem, LLC. 2-amino-3-sulfonyl-pyrazolo[1,5-a]pyrimidines substituées fonctionnant comme des antagonistes des récepteurs 5-ht6 de sérotonine, procédés de fabrication et d'utilisation
WO2009093209A2 (fr) 2008-01-24 2009-07-30 Alla Chem, Llc 2-alkylamino-3-arylsulfonyl-cyclo-alcano [e ou d] pyrazolo [1,5-a]pyrimidines substituées fonctionnant comme des antagonistes des récepteurs 5-ht6 de sérotonine, procédés de fabrication et d'utilisation
RU2384581C2 (ru) 2008-05-07 2010-03-20 Андрей Александрович Иващенко ЗАМЕЩЕННЫЕ 2-АМИНО-3-СУЛЬФОНИЛ-ТЕТРАГИДРО-ПИРАЗОЛО[1,5-a]ПИРИДО-ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
JP2012504663A (ja) 2008-10-06 2012-02-23 アンドレイ・アレクサンドロビッチ・イワシェンコ 置換された3−アリールスルホニル−ピラゾロ[1,5−a]ピリミジン、セロトニン5−HT6受容体アンタゴニスト、その調製のための方法及び使用
JP5747331B2 (ja) * 2008-11-27 2015-07-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 6,7,8,9−テトラヒドロ−5H−1,4,7,10a−テトラアザ−シクロヘプタ[f]インデン誘導体、これらの化合物を含有する医薬組成物、それらの使用及びそれらの調製方法
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
MX2013005478A (es) 2010-11-15 2013-08-29 Univ Leuven Kath Compuestos heterociclicos condensados antivirales.
RU2443697C1 (ru) 2010-12-21 2012-02-27 Александр Васильевич Иващенко Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения
MX342177B (es) 2011-09-30 2016-09-20 Ipsen Pharma Sas Inhibidores de cinasa 2 de repeticion rica en leucina (lrrk2) macrociclica.
TR201808280T4 (tr) * 2012-03-09 2018-07-23 Lexicon Pharmaceuticals Inc Pirazolo[1,5-a]pirimidin-bazlı bileşikler, bunları içeren bileşimler, ve bunların kullanım usulleri.
TW201542550A (zh) * 2013-09-06 2015-11-16 Lexicon Pharmaceuticals Inc 吡唑并[1,5-a]嘧啶基化合物、包含彼之組合物以及使用彼之方法
TW201620911A (zh) * 2014-03-17 2016-06-16 雷西肯製藥股份有限公司 銜接子關聯激酶1之抑制劑、包含其之組成物、及其使用方法
TW201625639A (zh) 2014-09-17 2016-07-16 腫瘤設計公司 巨環lrrk2激酶抑制劑
JP6789962B2 (ja) 2015-03-09 2020-11-25 オーリジーン ディスカバリー テクノロジーズ リミテッドAurigene Discovery Technologies Limited CDK阻害剤としてのピラゾロ[1,5−a][1,3,5]トリアジンとピラゾロ[1,5−a]ピリミジン誘導体
WO2017052394A1 (fr) * 2015-09-23 2017-03-30 Uniwersytet Jagielloński Composés d'imidazopyridine et leur utilisation comme ligands du récepteur 5-ht6
MX2018005342A (es) 2015-11-02 2018-08-15 Janseen Pharmaceutica Nv Compuesto de [1,2,4]triazolo[1,5-a]pirimidin-7-ilo.
CN109937202B (zh) 2016-11-02 2022-12-30 詹森药业有限公司 作为pde2抑制剂的[1,2,4]三唑并[1,5-a]嘧啶化合物
TWI764950B (zh) 2016-11-02 2022-05-21 比利時商健生藥品公司 Pde2抑制劑
WO2018083101A1 (fr) 2016-11-02 2018-05-11 Janssen Pharmaceutica Nv Composés de [1,2,4] triazolo [1,5-a] pyrimidine en tant qu'inhibiteurs de pde2
JP7671425B2 (ja) 2019-05-05 2025-05-02 ジェネンテック,インコーポレーテッド Cdk阻害剤
CN112142744A (zh) 2019-06-28 2020-12-29 上海瑛派药业有限公司 取代的稠合杂芳双环化合物作为激酶抑制剂及其应用
CN115209952B (zh) 2020-01-13 2025-05-30 维基分析有限公司 经取代的吡唑并嘧啶及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907799A (en) * 1971-08-16 1975-09-23 Icn Pharmaceuticals Xanthine oxidase inhibitors
US4921527A (en) * 1987-07-31 1990-05-01 E. I. Du Pont De Nemours And Company Herbicidal sulfonamides
EP0368897A1 (fr) 1987-07-31 1990-05-23 E.I. Du Pont De Nemours And Company Sulfonamides herbicides
DE3825043A1 (de) 1988-07-20 1990-02-15 Schering Ag 3-methylsulfonyl-pyrazolo(1,5-a)pyrimidin-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider, pflanzenwuchsregulierender und fungizider wirkung
US5571813A (en) * 1993-06-10 1996-11-05 Beiersdorf-Lilly Gmbh Fused pyrimidine compounds and their use as pharmaceuticals
AU7001396A (en) 1995-09-22 1997-04-09 Takeda Chemical Industries Ltd. Triazole compounds, their production and use
DZ2376A1 (fr) 1996-12-19 2002-12-28 Smithkline Beecham Plc Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
WO1998027058A2 (fr) 1996-12-19 1998-06-25 Smithkline Beecham Plc Nouveaux composes
EP0994862B1 (fr) 1997-07-11 2005-06-01 SmithKline Beecham plc Derives sulphonamide comme antagonistes du recepteur 5-ht6 et procede pour leur preparation

Also Published As

Publication number Publication date
CA2265095C (fr) 2008-07-22
DE69907784T2 (de) 2004-03-25
KR19990077741A (ko) 1999-10-25
IL128869A (en) 2003-09-17
ID23575A (id) 2000-05-04
MA26612A1 (fr) 2004-12-20
SI0941994T1 (en) 2003-10-31
BR9901095A (pt) 2000-05-02
NO991150L (no) 1999-09-13
HRP990077A2 (en) 2000-02-29
KR100313181B1 (ko) 2001-11-05
NZ334526A (en) 2000-07-28
JP2000186090A (ja) 2000-07-04
ES2198095T3 (es) 2004-01-16
IL128869A0 (en) 2000-01-31
TR199900531A2 (xx) 1999-10-21
JP3231288B2 (ja) 2001-11-19
CN1118468C (zh) 2003-08-20
SG78336A1 (en) 2001-02-20
AU752408B2 (en) 2002-09-19
NO312297B1 (no) 2002-04-22
HK1023343A1 (en) 2000-09-08
HRP990077B1 (en) 2003-08-31
HUP9900589A1 (hu) 2000-03-28
CZ82599A3 (cs) 1999-09-15
RU2218340C2 (ru) 2003-12-10
NO991150D0 (no) 1999-03-10
ZA991946B (en) 1999-09-13
DE69907784D1 (de) 2003-06-18
EP0941994B1 (fr) 2003-05-14
EP0941994A1 (fr) 1999-09-15
ATE240332T1 (de) 2003-05-15
PL331875A1 (en) 1999-09-13
CA2265095A1 (fr) 1999-09-11
AR016453A1 (es) 2001-07-04
MY119536A (en) 2005-06-30
CN1236780A (zh) 1999-12-01
AU2038399A (en) 1999-09-23
PT941994E (pt) 2003-09-30
YU12099A (sh) 2000-10-30
US6194410B1 (en) 2001-02-27
HU9900589D0 (en) 1999-05-28
TW585865B (en) 2004-05-01
TR199900531A3 (tr) 1999-10-21
CZ291514B6 (cs) 2003-03-12
UY25419A1 (es) 2001-11-30
PE20000337A1 (es) 2000-05-13

Similar Documents

Publication Publication Date Title
DK0941994T3 (da) Pyrazolopyrimidiner og pyrazolotriaziner med 5-HT6 receptoraffinitet
DE69911378D1 (de) Fluorierte ionomere und verwendung davon
FI973816A0 (fi) Polypropen med hoeg smaeltstyrka
NO992838D0 (no) Benzotiofenkarboksamid-derivater og PGD2 antagonister omfattende disse
DE59701856D1 (de) Kugelgelenk
DK0915880T3 (da) Azolotriaziner og pyrimidiner
DE69825327D1 (de) Prüfanordnung und Prüfverfahren
DK0906301T3 (da) Benzofurylderivater og anvendelsen deraf
DE69726837D1 (de) Kautschukzusammensetzung mit verminderter wärmeentwicklung und walzen
DE69736457D1 (de) Interatomares messverfahren
NO20004274D0 (no) Proteaseaktivert reseptor 4 og anvendelse derav
NO986174D0 (no) Triazinderivater og anvendelse derav
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
DK1025100T3 (da) 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf
FI962419A0 (fi) Ringoskillator med hoeg hastighet
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
NO20001718L (no) Benzen-fusjonerte heterocykliske derivater og anvendelse derav
NO991372L (no) Trinn med reflektorer
IT1288298B1 (it) Sedia scolastica e banco scolastico
FI962780L (fi) Syöttötuoli-porrasjakkara
DK39696A (da) Opblæselig konstruktion
DE69628756D1 (de) Kombinierte longitudinale und transversale Spurnachführung
DE59704118D1 (de) Sitzeinrichtung
NO20000038D0 (no) Benzodiazepinderivater og tilsvarende anvendelse og sammensetning
DE59803982D1 (de) Kugelgelenkanordnung